Valneva SE (VALN) Inventory (2020 - 2026)
Valneva SE's (VALN) quarterly Inventory came in at $59.2 million in Q1 2026, down 8.72% year-on-year from $64.9 million in Q1 2025, and up 1.28% quarter-over-quarter from $58.5 million in Q4 2025.
Valneva SE (VALN) Inventory (2020 - 2026) Analysis & Trends
Valneva SE has disclosed Inventory across 7 years of filings, most recently posting $59.2 million for Q1 2026.
- Inventory for Q1 2026 came in at $59.2 million, down 8.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $59.2 million (down 8.72% YoY), and the FY2025 annual result was $58.5 million, up 1.97% from the prior year.
- Inventory came in at $59.2 million for Q1 2026 at Valneva SE, up from $58.5 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $156.8 million in Q1 2022 to a low of $35.8 million in Q4 2022.
- The 5-year median for Inventory is $58.5 million (2025), against an average of $65.5 million.
- Across the five-year window, Inventory slumped 74.77% in 2022 and jumped 53.53% in 2024, its largest moves.
- Valneva SE's Inventory stood at $35.8 million in 2022, then soared by 33.58% to $47.8 million in 2023, then gained by 19.86% to $57.3 million in 2024, then rose by 1.97% to $58.5 million in 2025, then increased by 1.28% to $59.2 million in 2026.
- The last three Inventory figures came in at $59.2 million (Q1 2026), $58.5 million (Q4 2025), and $75.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | 59.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.22 Mn |
| Dec 31, 2025 | 58.47 Mn |
| Sep 30, 2025 | 75.16 Mn |
| Jun 30, 2025 | 69.88 Mn |
| Mar 31, 2025 | 64.88 Mn |
| Dec 31, 2024 | 57.34 Mn |
| Sep 30, 2024 | 63.51 Mn |
| Jun 30, 2024 | 52.62 Mn |
| Mar 31, 2024 | 52.78 Mn |
| Dec 31, 2023 | 47.84 Mn |
| Sep 30, 2023 | 41.37 Mn |
| Jun 30, 2023 | 36.32 Mn |
| Mar 31, 2023 | 41.86 Mn |
| Dec 31, 2022 | 35.81 Mn |
| Sep 30, 2022 | 97.26 Mn |
| Jun 30, 2022 | 101.58 Mn |
| Mar 31, 2022 | 156.82 Mn |
| Dec 31, 2021 | 141.96 Mn |
| Dec 31, 2020 | 32.11 Mn |